{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:10:06Z","timestamp":1784304606725,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-01675-2","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:15:44Z","timestamp":1749096944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exploring the potential of digital biomarkers as a measure of brain health \u2018capital\u2019"],"prefix":"10.1038","volume":"8","author":[{"given":"Dylan","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donncha","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Welstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"1675_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"VL Feigin","year":"2020","unstructured":"Feigin, V. L. et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 19, 255\u2013265 (2020).","journal-title":"Lancet Neurol."},{"key":"1675_CR2","unstructured":"World Health Organization. Brain health. https:\/\/www.who.int\/health-topics\/brain-health#tab=tab_2 (accessed 21 May, 2025)."},{"key":"1675_CR3","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. Defining brain health: A concept analysis. Int. J. Geriatr. Psychiatry 2022;37. https:\/\/doi.org\/10.1002\/GPS.5564.","DOI":"10.1002\/GPS.5564"},{"key":"1675_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/026988119901300207","volume":"13","author":"JN Beuzen","year":"1999","unstructured":"Beuzen, J. N., Taylor, N., Wesnes, K. & Wood, A. A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J. Psychopharmacol. 13, 152\u2013158 (1999).","journal-title":"J. Psychopharmacol."},{"key":"1675_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.14283\/jpad.2023.47","volume":"10","author":"SW Peng","year":"2023","unstructured":"Peng, S. W. et al. Subjective cognitive complaints: comparing the relation between self-reported versus informant-reported subjective cognitive complaints and cognitive performances in cognitively unimpaired, mild cognitive impairment and populations with dementia. J. Prev. Alzheimers Dis. 10, 562\u2013570 (2023).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"1675_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413\u2013446 (2020).","journal-title":"Lancet"},{"key":"1675_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz, J. D. et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23, 344\u2013381 (2024).","journal-title":"Lancet Neurol."},{"key":"1675_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"VL Feigin","year":"2017","unstructured":"Feigin, V. L. et al. Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 16, 877\u2013897 (2017).","journal-title":"Lancet Neurol."},{"key":"1675_CR9","doi-asserted-by":"crossref","unstructured":"Powell, D. Walk, talk, think, see and feel: harnessing the power of digital biomarkers in healthcare. npj Digit. Med. 7, 45 (2024).","DOI":"10.1038\/s41746-024-01023-w"},{"key":"1675_CR10","doi-asserted-by":"publisher","first-page":"e12376","DOI":"10.1002\/trc2.12376","volume":"9","author":"H Cogo-Moreira","year":"2023","unstructured":"Cogo-Moreira, H. et al. State, trait, and accumulated features of the Alzheimer\u2019s Disease Assessment Scale Cognitive Subscale (ADAS-Cog) in mild Alzheimer\u2019s disease. Alzheimer\u2019s. Dement.: Transl. Res. Clin. Interven. 9, e12376 (2023).","journal-title":"Alzheimer\u2019s. Dement.: Transl. Res. Clin. Interven."},{"key":"1675_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/alz.12773","volume":"19","author":"RJ Jutten","year":"2023","unstructured":"Jutten, R. J. et al. Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer\u2019s disease. Alzheimer\u2019s. Dement. 19, 708\u2013720 (2023).","journal-title":"Alzheimer\u2019s. Dement."},{"key":"1675_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41746-019-0119-8","volume":"2","author":"A Coravos","year":"2019","unstructured":"Coravos, A., Khozin, S. & Mandl, K. D. Developing and adopting safe and effective digital biomarkers to improve patient outcomes. npj Digit. Med. 2, 40 (2019).","journal-title":"npj Digit. Med."},{"key":"1675_CR13","doi-asserted-by":"crossref","unstructured":"Bakker, J. P. et al. A systematic review of feasibility studies promoting the use of mobile technologies in clinical research. npj Digit. Med. 2, 47 (2019).","DOI":"10.1038\/s41746-019-0125-x"},{"key":"1675_CR14","unstructured":"Optimizing brain health across the life course: WHO position paper [Internet]. [cited 2025 Apr 22]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240054561"},{"key":"1675_CR15","doi-asserted-by":"crossref","unstructured":"Bakker, J. P. et al. V3+ extends the V3 framework to ensure user-centricity and scalability of sensor-based digital health technologies. npj Digit. Med. 8, 51 (2025).","DOI":"10.1038\/s41746-024-01322-2"},{"key":"1675_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-024-01374-4","volume":"8","author":"A Mahajan","year":"2025","unstructured":"Mahajan, A. & Powell, D. Improving authenticity and provenance in digital biomarkers: the case for digital watermarking. npj Digit. Med. 8, 1\u20133 (2025).","journal-title":"npj Digit. Med."},{"key":"1675_CR17","doi-asserted-by":"crossref","unstructured":"Manta, C., Patrick-Lake, B. & Goldsack, J. C. Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health. Digit. Biomark. 4, 69\u201377 (2020).","DOI":"10.1159\/000509725"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01675-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01675-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01675-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:45:37Z","timestamp":1750160737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01675-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1675"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01675-2","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.P. is a News & Views editor at npj Digital Medicine and played no role in the internal review or decision to publish this News & Views article. JH is a Director and shareholder in Metis Cognition Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}